small molecule

CLINDAMYCIN PHOSPHATE

CLINDAMYCIN PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLINDAMYCIN PHOSPHATE
Active ingredientCLINDAMYCIN PHOSPHATE
StrengthEQ 1% BASE
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalNovember 2022
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.